Does ATENOLOL Cause Interstitial lung disease? 149 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Interstitial lung disease have been filed in association with ATENOLOL (Atenolol and Chlorthalidone). This represents 1.2% of all adverse event reports for ATENOLOL.
149
Reports of Interstitial lung disease with ATENOLOL
1.2%
of all ATENOLOL reports
20
Deaths
109
Hospitalizations
How Dangerous Is Interstitial lung disease From ATENOLOL?
Of the 149 reports, 20 (13.4%) resulted in death, 109 (73.2%) required hospitalization, and 8 (5.4%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATENOLOL. However, 149 reports have been filed with the FAERS database.
What Other Side Effects Does ATENOLOL Cause?
Drug ineffective (1,231)
Hypotension (1,121)
Bradycardia (942)
Completed suicide (928)
Dyspnoea (791)
Toxicity to various agents (742)
Nausea (652)
Fatigue (649)
Off label use (638)
Dizziness (632)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ATENOLOL Alternatives Have Lower Interstitial lung disease Risk?
ATENOLOL vs ATENOLOL\CHLORTHALIDONE
ATENOLOL vs ATEZOLIZUMAB
ATENOLOL vs ATLANTIC SALMON OIL
ATENOLOL vs ATOGEPANT
ATENOLOL vs ATOMOXETINE